PTEN and cancer: The authors suggested a model in which the minor allele of 19p13.3 impairs mTOR signaling, conferring selective pressure to later somatic mutation of PTEN. In terms of cancer prevention, genome-wide association studies (GWAS) have identified many common low-penetrance germline variants that are linked with cancer predisposition, providing direct evidence of polygenic susceptibility.